Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Incyte Corporation (INCY) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Incyte Corporation (INCY) - free report >>
Image: Bigstock
New Strong Buy Stocks for August 10th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
• Acxiom Corporation operates as an enterprise data, analytics, and software-as-a-service company in the United States, Europe, the Asia-Pacific, and internationally. The Zacks Consensus Estimate for its current year earnings has soared by 28.9% over the last 30 days.
• Chimera Investment Corporation (CIM - Free Report) is a real estate investment trust. The company is primarily engaged in the business of investing, on a leveraged basis, in a diversified portfolio of mortgage assets. The Zacks Consensus Estimate for its current year earnings has improved by 1.4% over the last 30 days.
• Galena Biopharma Inc focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. It has seen the Zacks Consensus Estimate for its current year earnings increase 2.7% over the last 30 days.
• Incyte Corporation (INCY - Free Report) is a biopharmaceutical company. The company is focused on the discovery, development and commercialization of therapeutics to treat medical needs, primarily in oncology. The Zacks Consensus Estimate for its current year earnings has surged by 200% over the last 30 days.
• NGL Energy Partners LP (NGL - Free Report) engages in the crude oil logistics, water solutions, liquids, retail propane, and refined products and renewables businesses in the United States. The Zacks Consensus Estimate revision for its current year earnings was a positive 1.4% over the last 30 days.
Confidential from Zacks
Would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to access these private picks >>.